Vol. 22/No. 5 | OncologyLive

Ki-67 Is Poised to Advance as a Biomarker in Early-Stage Breast Cancer

March 24, 2021

Although Ki-67 is a commonly used measure of cellular proliferation in breast cancer tissue, its utility as a biomarker for helping to guide therapy decisions has been clouded by technical and clinical questions.

Investigators Focus Devimistat Study on Older Patients With AML

March 15, 2021

Devimistat, a small molecule that targets enzymes involved in cancer cell metabolism, holds promise for older patients with relapsed or refractory acute myeloid leukemia who typically have a poor prognosis with standard-of-care chemotherapy

COVID-19 Spurs New Therapy Trends

March 12, 2021

When the coronavirus disease 2019 pandemic started upending health care services throughout the United States a year ago, the oncology community moved quickly to develop guidance on selecting therapies and setting treatment schedules for many cancers to allow for less frequent in-patient visits to clinics and infusion centers.